常染色体显性多囊肾病肾功能下降模式:HALT-PKD试验事后分析
该研究对HALT-PKD试验中494名Study A和435名Study B参与者进行事后分析,采用贝叶斯模型评估个体eGFR轨迹。大多数参与者(Study A 62.5%,Study B 81%)呈线性下降,但15.5%和6%分别有持续至少4.5年的稳定eGFR期。稳定者肾脏体积更小、肾血流量更高、尿白蛋白排泄更低、BMI更低。
要点
- ADPKD患者eGFR下降多为线性,但部分可长期稳定。
- 稳定eGFR者基线肾脏体积更小、肾血流量更高、BMI更低。
- 非进展者中三分之二携带PKD1突变,富集弱非截短突变。
核心结论
- 多数ADPKD患者eGFR呈线性下降,但相当比例存在长期稳定期。
- 早期ADPKD中较低BMI与更稳定肾功能相关。
研究设计与样本
- HALT-PKD试验事后纵向分析,纳入Study A 494例和Study B 435例随访>3年且eGFR评估≥7次者。
主要发现
- Study A中62.5%、Study B中81%参与者eGFR呈线性下降。
- Study A中22%、Study B中13%进展者呈非线性下降模式。
- Study A中15.5%、Study B中6%参与者有持续≥4.5年的稳定eGFR期。
- 稳定者(Study A)总肾脏体积更小、肾血流量更高、尿白蛋白排泄更低、BMI更低。
- 两项研究中非进展者三分之二有PKD1突变,富集弱非截短突变。
关键数值与推荐
- eGFR采用CKD-EPI肌酐方程评估。
- 稳定eGFR定义为持续≥4.5年。
临床怎么用
- ADPKD患者肾功能下降模式异质,部分可长期稳定,应个体化监测。
- 较低BMI可能与早期ADPKD肾功能稳定相关。
局限性
- 临床试验人群随访时间相对较短。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous clinical studies of autosomal dominant polycystic kidney disease (ADPKD) reported that loss of kidney function usually follows a steep and relentless course. A detailed examination of individual patterns of decline in estimated glomerular filtration rate (eGFR) has not been performed. STUDY DESIGN: Longitudinal post hoc analysis of data collected during the Halt Progression of Polycystic Kidney Disease (HALT-PKD) trials. SETTING & PARTICIPANTS: 494 HALT-PKD Study A participants (younger; preserved eGFR) and 435 Study B participants (older; reduced eGFR) who had more than 3 years of follow-up and 7 or more eGFR assessments. MEASUREMENTS: Longitudinal eGFR assessments using the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) creatinine equation. PREDICTORS: Demographic, clinical, laboratory, and imaging features of participants. OUTCOMES: Probability of linear and nonlinear decline patterns or of stable eGFR calculated for each participant from a Bayesian model of individual eGFR trajectories. RESULTS: Most (62.5% in Study A and 81% in Study B) participants had a linear decline in eGFR during up to 8 years of follow-up. A proportion (22% in Study A and 13% in Study B) of progressors had a nonlinear pattern. 15.5% of participants in Study A and 6% in Study B had a prolonged (≥4.5 years) period of stable eGFRs. These individuals (Study A) had significantly smaller total kidney volumes, higher renal blood flows, lower urinary albumin excretion, and lower body mass index at baseline and study end. In Study B, participants with reduced but stable eGFRs were older than the progressors. Two-thirds of nonprogressors in both studies had PKD1 mutations, with enrichment for weak nontruncating mutations. LIMITATIONS: Relatively short follow-up of a clinical trial population. CONCLUSIONS: Although many individuals with ADPKD have a linear decline in eGFR, prolonged intervals of stable GFRs occur in a substantial fraction. Lower body mass index was associated with more stable kidney function in early ADPKD.
引用
- Brosnahan GM, Abebe KZ, Moore CG, et al. Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials. Am J Kidney Dis. 2018. PMID: 29306517. doi:10.1053/j.ajkd.2017.10.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。